1 Mullin, J.W., Crystallization, Butterworth-Heinemann, Oxford, 368—402(1993). 2 Meenan, P.A., Anderson, S.R., Klug, D.L., “The Influ-ence of impurities and solvents on crystallization”, In: Handbook of Industrial Crystallization (2nd ed.), But-terworth-Heinemann, Boston, 67—97(2002). 3 Davey, R.J., Mullin, J.W., Whiting, M.J.L, “Habit modi-fication of succinic acid crystals grown from different solvents”, J. Cryst. Growth, 58, 304—312(1982). 4 Nokhodchi, A., Bolourtchian, N., Dinarvand, R., “Crys-tal modification of phenytoin using different solvents and crystallization conditions”, Int. J. Pharm., 250(1), 85—97(2003). 5 Bhat, M.N., Dharmaprakash, S.M., “Effect of solvents on the growth morphology and physical characteristics of nonlinear optical g-glycine crystals”, J. Cryst. Growth, 242(1/2), 245—252 (2002). 6 Cano, H., Gabas, N., Canselier, J.P., “Experimental study on the ibuprofen crystal growth morphology in solution”, J. Cryst. Growth, 224(3/4), 335—341(2001). 7 Prasad, K.V.R., Ristic, R.I., Sheen, D.B., Sherwood, J.N., “Crystallization of paracetamol from solution in the presence and absence of impurity”, Int. J. Pharm., 215(1/2), 29—44 (2001). 8 Garside, J., Davey, R.J., Jones, A.G., Advances in Indus-trial crystallization, Butterworth, Oxford (1993). 9 Femi-Oyewo, M.N., Spring, M.S., “Studies on paracetamol crystals produced by growth in aqueous so-lutions”, Int. J. Pharm., 112, 17—28(1994). 10 Xu, G., Handbook of Intermediate of Pharmaceuticals, Chemical Industry Press, Beijing (2001). (in Chinese) 11 York, P., “Solid-state properties of powders in the for-mulation and processing of solid dosage forms”, Int. J. Pharm., 14, 1—28(1983). 12 Peterson, D.H., Meister, P.D., Weintraub, A., Reineke, L.M., Eppstein, S.H., Murray, H.C., Leigh Osborn, H.M., “Microbiological transformation of steroids. XIII. Oxy-genation of 16α,l7α-oxidoprogesterone to 11 α-Hydroxy-l6α, 17α-oxidoprogesterone by Rhizopus Ni-gricans Ehrb. (A.T.C.C.6227b)”, J. Am. Chem. Soc., 77(16), 4428—4429(1955). 13 Zhang, L., Zhang, M., “Improved process of microbial 11-hydroxylation of 16,17-epoxyprogesterone”, Yaoxue Tongbao, 22, 7—8(1987). (in Chinese) 14 Nie, Q., “Study on the separation and purification of two isomorphic steroids”, Ph.D. Thesis, Tianjin University, 38—46(2007). (in Chinese) 15 Rosenberger, F., Riveros, H.G., “Segregation in alkali halide crystallization from aqueous solution”, J. Chem. Phys., 60, 668—674(1974). 16 Givand, J.C., Chang, B.K., Teja, A.S., Rousseau.R.W., “Distribution of isomorphic amino acids between a crys-tal phase and an aqueous solution”, Ind. Eng. Chem. Res., 41, 1873—1876(2002). 17 Wang, S., Wang, Y., Nie, Q., Wu, J.H., “16α, 17-Epoxy-4-pregnene-3,20-dione”, Acta Cryst., E60, o2337—o2338(2004). 18 Wang, Y., Wang, S., Hao, H., Chen, W., Nie, Q., “11-Hydroxy-16,17-epoxypregn-3,20-dione”, Acta Cryst., E60, o1338—o1339(2004). 19 Goetschel, R., Bar, R., “Formation of mixed crystals in microbial conversion of sterols and steroids”, Enzyme Microbial. Technol., 14, 462—469(1992). 20 Christiansen, L., Karjalainen, N., Serimaa, A., Lonnroth, N., Paakkari, T., Yliruusi, J., “Phase behaviour of beta-sitosterol-cholesterol and beta-sitostanol-cholesterol coprecipitates”, STP Pharma. Sci., 11(2), 167—173(2001).
|